A Description Of Real-World Treatment With Abiraterone Acetate In Metastatic Castration-Resistant Prostate Cancer Patients In The Post-Chemotherapy Setting In France And The Netherlands

Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden

Scandinavian Journal of Urology ◽

10.3109/21681805.2016.1172254 ◽

2016 ◽

Vol 50 (4) ◽

pp. 286-291 ◽

Cited By ~ 8

Author(s):

Johanna Svensson ◽

Emelie Andersson ◽

Ulf Persson ◽

Thomas Edekling ◽

Anna Ovanfors ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Cancer Patients ◽

Real World ◽

Abiraterone Acetate ◽

The Real ◽

713 ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITHOUT PRIOR CHEMOTHERAPY - INTERIM ANALYSIS OF THE COU-AA-302 PHASE 3 TRIAL

The Journal of Urology ◽

10.1016/j.juro.2013.02.272 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Fred Saad ◽

Neal D Shore ◽

Hendrik Van Poppel ◽

Dana Rathkopf ◽

Matthew R. Smith ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Interim Analysis ◽

Abiraterone Acetate ◽

Phase 3 ◽

Prior Chemotherapy ◽

Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

European Urology Oncology ◽

10.1016/j.euo.2019.01.008 ◽

2020 ◽

Vol 3 (1) ◽

pp. 119-127 ◽

Cited By ~ 2

Author(s):

Eleni Efstathiou ◽

Mark Titus ◽

Sijin Wen ◽

Patricia Troncoso ◽

Anh Hoang ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort

Cancer Medicine ◽

10.1002/cam4.3101 ◽

2020 ◽

Vol 9 (13) ◽

pp. 4613-4621

Author(s):

Jasmine Lim ◽

Akara Amantakul ◽

Nisha Shariff ◽

Bannakij Lojanapiwat ◽

Adlinda Alip ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcomes ◽

Real World ◽

Treatment Duration ◽

Abiraterone Acetate ◽

Southeast Asian ◽

Castration Resistant ◽

Asian Cohort

Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

Value in Health ◽

10.1016/j.jval.2013.08.1908 ◽

2013 ◽

Vol 16 (7) ◽

pp. A665 ◽

Cited By ~ 1

Author(s):

V. Vitale ◽

E. Asano ◽

M.L. Pereira

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Cancer Patients ◽

Impact Analysis ◽

Budget Impact ◽

Abiraterone Acetate ◽

Private Health Care ◽

Castration Resistant ◽

Previously Treated

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

Frontiers in Pharmacology ◽

10.3389/fphar.2017.00836 ◽

2017 ◽

Vol 8 ◽

Author(s):

Jian-Ri Li ◽

Kun-Yuan Chiu ◽

Shian-Shiang Wang ◽

Cheng-Kuang Yang ◽

Chuan-Shu Chen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Combined Androgen Blockade ◽

Castration Resistant ◽

Androgen Blockade

Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate–Treated Castration-Resistant Prostate Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-1549 ◽

2015 ◽

Vol 21 (14) ◽

pp. 3170-3177 ◽

Cited By ~ 36

Author(s):

Xu S. Xu ◽

Charles J. Ryan ◽

Kim Stuyckens ◽

Matthew R. Smith ◽

Fred Saad ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Abiraterone Acetate ◽

772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

European Urology Supplements ◽

10.1016/s1569-9056(16)60774-1 ◽

2016 ◽

Vol 15 (3) ◽

pp. e772-e772a

Author(s):

C. Van Praet ◽

S. Rottey ◽

F. Van Hende ◽

G. Pelgrims ◽

W. Demey ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Re: Safety and Outcomes of New Generation Hormone-Therapy in Elderly Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Patients in the Real World

The Journal of Urology ◽

10.1097/01.ju.0000614716.98376.19 ◽

2020 ◽

Vol 203 (2) ◽

pp. 230-230

Author(s):

Tomas L. Griebling

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Cancer Patients ◽

Real World ◽

The Real ◽

Castration Resistant ◽

New Generation

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Future Oncology ◽

10.2217/fon-2018-0635 ◽

2019 ◽

Vol 15 (13) ◽

pp. 1469-1479 ◽

Cited By ~ 5

Author(s):

Cem Onal ◽

Ali Murat Sedef ◽

Fatih Kose ◽

Ezgi Oymak ◽

Ozan Cem Guler ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽